SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-079580
Filing Date
2013-10-31
Accepted
2013-10-31 12:51:08
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19533_110q.htm 10-Q 1289565
2 EX-31.1 a13-19533_1ex31d1.htm EX-31.1 11943
3 EX-31.2 a13-19533_1ex31d2.htm EX-31.2 11948
4 EX-32.1 a13-19533_1ex32d1.htm EX-32.1 7839
  Complete submission text file 0001104659-13-079580.txt   11094018

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vphm-20130930.xml EX-101.INS 1400991
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vphm-20130930.xsd EX-101.SCH 94984
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vphm-20130930_cal.xml EX-101.CAL 79856
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vphm-20130930_def.xml EX-101.DEF 528954
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT vphm-20130930_lab.xml EX-101.LAB 1581833
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vphm-20130930_pre.xml EX-101.PRE 865670
Mailing Address 730 STOCKTON DRIVE EXTON PA 19341
Business Address 730 STOCKTON DRIVE EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21699 | Film No.: 131181730
SIC: 2834 Pharmaceutical Preparations